Novel Biomarkers for Personalized Cancer Immunotherapy

Cancer immunotherapy has emerged as a novel and effective treatment strategy for several types of cancer. Immune checkpoint inhibitors (ICIs) have recently demonstrated impressive clinical benefit in some advanced cancers. Nonetheless, in the majority of patients, the successful use of ICIs is limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Shindo, Yoshitaro, Hazama, Shoichi, Tsunedomi, Ryouichi, Suzuki, Nobuaki, Nagano, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770350/
https://www.ncbi.nlm.nih.gov/pubmed/31443339
http://dx.doi.org/10.3390/cancers11091223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770350/
https://www.ncbi.nlm.nih.gov/pubmed/31443339
http://dx.doi.org/10.3390/cancers11091223

Ejemplares similares